Karyopharm Therapeutics Market Risk Adjusted Performance
| KPTI Stock | | | USD 8.75 0.52 6.32% |
The Market Risk Adjusted Performance lookup presents technical context for Karyopharm Therapeutics and related instruments. Data availability can vary by region and feed;
Equity Screeners provides broader screening access. Karyopharm Therapeutics has a market cap of 160.51 M, operating margin of -52.36%, ROE of -8.91%.
Correlation Analysis can help frame allocation decisions. The allocation includes a position in Karyopharm Therapeutics inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
Explore our
How to Trade Karyopharm Stock guide to learn how to trade Karyopharm Therapeutics effectively.
Karyopharm Therapeutics has current Market Risk Adjusted Performance of 3.49.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 3.49 | |
| ER[a] | = | Expected return on investing in Karyopharm Therapeutics |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Karyopharm Therapeutics Market Risk Adjusted Performance Peers Comparison
Karyopharm Market Risk Adjusted Performance Relative To Other Indicators
Karyopharm Therapeutics is currently recognized as the top-ranked stock in market risk adjusted performance category among its top competitors. It is currently under evaluation. in maximum drawdown category among its top competitors reporting about
8.21 of Maximum Drawdown per Market Risk Adjusted Performance. The ratio of Maximum Drawdown to Market Risk Adjusted Performance for Karyopharm Therapeutics is roughly
8.21 Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.